Episodios

  • Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
    Jun 18 2025

    Prof Meletios-Athanasios (Thanos) C Dimopoulos from the National and Kapodistrian University of Athens and Alexandra Hospital in Athens, Greece, and Dr Robert Z Orlowski from The University of Texas MD Anderson Cancer Center in Houston, Texas, provide their perspectives on relevant new clinical data in multiple myeloma and their application to disease treatment.

    CME information and select publications here.

    Más Menos
    59 m
  • Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
    Jun 11 2025

    Professor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer Institute in New York, New York, provide their perspectives on relevant new clinical data in myelofibrosis and discuss their application to treatment.

    CME information and select publications here.

    Más Menos
    59 m
  • Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
    Jun 5 2025

    Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma.

    CME information and select publications here.

    Más Menos
    59 m
  • Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
    Jun 2 2025

    Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. 

    CME information and select publications here.

    Más Menos
    48 m
  • Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
    May 31 2025

    Clinical investigators discuss available data guiding the management of multiple myeloma. 

    CME information and select publications here.

    Más Menos
    51 m
  • Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    May 29 2025

    Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapsed/refractory multiple myeloma.

    CME information and select publications here.

    Más Menos
    51 m
  • Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    May 25 2025

    Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia.

    CME information and select publications here.

    Más Menos
    48 m
  • Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
    May 23 2025

    Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.

    CME information and select publications here.

    Más Menos
    43 m
adbl_web_global_use_to_activate_webcro805_stickypopup